Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Icahn School of Medicine at Mount Sinai

Icahn School of Medicine at Mount Sinai in New York, New York, United States is listed as a site for 1,228 registered clinical trials, 377 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,228
Ongoing 377

This page covers the site record Icahn School of Medicine at Mount Sinai in New York, New York, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Icahn School of Medicine at Mount Sinai, also sponsors trials.

Get the Icahn School of Medicine at Mount Sinai report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,228 trials counted.

  • Phase 1 151 trials
  • Phase 1/2 68 trials
  • Phase 2 252 trials
  • Phase 2/3 21 trials
  • Phase 3 171 trials
  • Phase 4 76 trials
  • Not applicable 305 trials
  • Observational 172 trials
  • Expanded access 11 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 379 trials
  • Completed 639 trials
  • Terminated 177 trials
  • Other 33 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Expanded access, Unknown)

Top of scale: 103

1995: 1 trials (Phase 4 1) 1998: 1 trials (Observational 1) 2002: 1 trials (Phase 4 1) 2003: 3 trials (Phase 3 1, Phase 2 1, Phase 1 1) 2004: 3 trials (Not applicable 1, Phase 4 1, Phase 3 1) 2005: 9 trials (Observational 1, Not applicable 4, Phase 4 1, Phase 3 1, Phase 2 2) 2006: 6 trials (Observational 2, Not applicable 2, Phase 4 1, Phase 2 1) 2007: 7 trials (Observational 1, Not applicable 2, Phase 3 1, Phase 2 1, Phase 1/2 1, Phase 1 1) 2008: 9 trials (Observational 1, Not applicable 1, Phase 4 3, Phase 3 1, Phase 1/2 3) 2009: 10 trials (Observational 3, Not applicable 4, Phase 2 1, Phase 1/2 1, Phase 1 1) 2010: 18 trials (Observational 3, Not applicable 7, Phase 4 3, Phase 3 1, Phase 2 2, Phase 1/2 1, Phase 1 1) 2011: 32 trials (Observational 6, Not applicable 16, Phase 4 3, Phase 3 2, Phase 2 2, Phase 1/2 1, Phase 1 2) 2012: 42 trials (Observational 12, Not applicable 11, Phase 4 6, Phase 3 3, Phase 2 8, Phase 1 2) 2013: 48 trials (Observational 8, Not applicable 11, Phase 4 5, Phase 3 2, Phase 2 15, Phase 1/2 3, Phase 1 4) 2014: 59 trials (Other 1, Observational 10, Not applicable 13, Phase 4 4, Phase 3 5, Phase 2/3 2, Phase 2 17, Phase 1/2 5, Phase 1 2) 2015: 65 trials (Observational 19, Not applicable 14, Phase 4 2, Phase 3 8, Phase 2/3 1, Phase 2 12, Phase 1/2 2, Phase 1 7) 2016: 57 trials (Observational 7, Not applicable 20, Phase 4 3, Phase 3 8, Phase 2/3 2, Phase 2 8, Phase 1/2 1, Phase 1 8) 2017: 89 trials (Observational 12, Not applicable 26, Phase 4 5, Phase 3 16, Phase 2 19, Phase 1/2 5, Phase 1 6) 2018: 93 trials (Other 1, Observational 15, Not applicable 18, Phase 4 7, Phase 3 11, Phase 2/3 2, Phase 2 22, Phase 1/2 3, Phase 1 14) 2019: 83 trials (Observational 8, Not applicable 18, Phase 4 4, Phase 3 14, Phase 2/3 2, Phase 2 13, Phase 1/2 11, Phase 1 13) 2020: 82 trials (Observational 11, Not applicable 18, Phase 4 6, Phase 3 11, Phase 2/3 2, Phase 2 15, Phase 1/2 9, Phase 1 10) 2021: 103 trials (Observational 11, Not applicable 25, Phase 4 4, Phase 3 18, Phase 2/3 3, Phase 2 27, Phase 1/2 3, Phase 1 12) 2022: 80 trials (Observational 11, Not applicable 16, Phase 4 2, Phase 3 10, Phase 2/3 1, Phase 2 17, Phase 1/2 4, Phase 1 19) 2023: 91 trials (Observational 9, Not applicable 25, Phase 4 3, Phase 3 13, Phase 2/3 1, Phase 2 18, Phase 1/2 4, Phase 1 18) 2024: 83 trials (Observational 8, Not applicable 16, Phase 4 5, Phase 3 13, Phase 2 21, Phase 1/2 5, Phase 1 15) 2025: 86 trials (Observational 8, Not applicable 19, Phase 4 2, Phase 3 25, Phase 2/3 5, Phase 2 15, Phase 1/2 1, Phase 1 11)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 57
2025 86
2024 83
2023 91
2022 80
2021 103
2020 82
2019 83
2018 93
2017 89

Showing 10 of 27 years.

Start your 14-day trial Email me all 27 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,228 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 285 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 511 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF